Informational use only
The website is provided for general information, product demonstration and controlled investor discussion. Content may be incomplete, updated or withdrawn without notice and must not be relied on as professional advice.
Terms of use
Website, demonstration and investor-material terms.
Review draft · final terms require legal approval before public release.
Permitted use
You may review public content for lawful personal or professional evaluation. You may not misrepresent REGNR8 content, remove notices, attempt unauthorised access, interfere with the website or use demo outputs for clinical or investment decision-making.
Intellectual property
REGNR8 names, marks, content, interface concepts, governance structures and demo materials remain subject to applicable intellectual-property and contractual rights. No licence is granted except the limited right to view authorised content.
Confidential materials
Materials supplied through investor access remain subject to their confidentiality markings, NDA terms and stated review purpose. They must not be copied, forwarded, published or used to solicit others without written authority.
No offer or advice
Nothing on the website is an offer, solicitation, recommendation, allocation, reservation of shares or investment advice. Investor participation can arise only through definitive documentation after applicable review.
Health boundary
The website and demo do not provide diagnosis, treatment, prescribing, medication changes, emergency support or a replacement for qualified care. See the Health Disclaimer.
Limitation and review status
To the extent permitted by applicable law, use is at the visitor’s own risk. These review-draft terms require legal confirmation of governing law, jurisdiction, liability wording, contact details and consumer-law requirements before publication.